| scholarly article | Q13442814 |
| P2093 | author name string | Ying Sun | |
| Yong Han | |||
| Zhao Chen | |||
| Qiang Lu | |||
| Xiao-Fei Li | |||
| Xiao-Long Yan | |||
| Zhi-Pei Zhang | |||
| Xue-Jiao Wang | |||
| Wu-Ping Wang | |||
| Jin-Bo Zhao | |||
| Yun-Feng Ni | |||
| Ju-Zheng Wang | |||
| P2860 | cites work | Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas | Q22010990 |
| Global cancer statistics, 2002 | Q27860562 | ||
| Epithelial-mesenchymal transitions in development and disease | Q27860630 | ||
| Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis | Q28283104 | ||
| Complex networks orchestrate epithelial-mesenchymal transitions | Q29547478 | ||
| Lung cancer | Q29615473 | ||
| In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro | Q29617927 | ||
| Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance | Q33851157 | ||
| Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells | Q34028736 | ||
| FoxQ1 overexpression influences poor prognosis in non-small cell lung cancer, associates with the phenomenon of EMT. | Q34326636 | ||
| Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma | Q34583510 | ||
| Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition | Q34677454 | ||
| L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer | Q35416836 | ||
| Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer | Q35958155 | ||
| Identification of a novel role of RING finger protein 11 promoting the metastasis of murine melanoma cells | Q36225861 | ||
| YAP is a critical oncogene in human cholangiocarcinoma | Q36232005 | ||
| Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway | Q36346927 | ||
| High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis | Q36546475 | ||
| Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell | Q36764852 | ||
| Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma. | Q36863127 | ||
| LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway | Q37369888 | ||
| Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer | Q38054713 | ||
| Regulatory networks defining EMT during cancer initiation and progression | Q38076317 | ||
| Lung cancer in China: challenges and interventions | Q38094966 | ||
| Status of anti-lung cancer drug patents applications in China from 2003 to 2012. | Q38156487 | ||
| Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer | Q38786493 | ||
| Gankyrin facilitates follicle-stimulating hormone-driven ovarian cancer cell proliferation through the PI3K/AKT/HIF-1α/cyclin D1 pathway | Q38835733 | ||
| JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells | Q39020685 | ||
| Gankyrin is essential for hypoxia enhanced metastatic potential in breast cancer cells | Q39043522 | ||
| Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6. | Q39099246 | ||
| Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer | Q39134905 | ||
| Gankyrin activates IL-8 to promote hepatic metastasis of colorectal cancer | Q39168162 | ||
| Gankyrin is frequently overexpressed in breast cancer and is associated with ErbB2 expression | Q39218576 | ||
| Gankyrin promotes breast cancer cell metastasis by regulating Rac1 activity | Q39298025 | ||
| The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours | Q39512984 | ||
| Gankyrin promotes the proliferation of human pancreatic cancer | Q39702569 | ||
| Upregulated fascin1 in non-small cell lung cancer promotes the migration and invasiveness, but not proliferation | Q39788953 | ||
| Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance | Q40068246 | ||
| Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling. | Q40468389 | ||
| International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. | Q45110608 | ||
| Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. | Q53090136 | ||
| Ep-CAM overexpression in breast cancer as a predictor of survival | Q73328477 | ||
| Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers | Q84772564 | ||
| [Epithelial-mesenchymal transition in non-small cell lung cancer] | Q85226803 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 5909-5923 | |
| P577 | publication date | 2016-12-15 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway | |
| P478 | volume | 8 |
| Q93187485 | DHX9 inhibits epithelial-mesenchymal transition in human lung adenocarcinoma cells by regulating STAT3 |
| Q89572810 | Fingolimod inhibits proliferation and epithelial-mesenchymal transition in sacral chordoma by inactivating IL-6/STAT3 signalling |
| Q90989203 | KIFC1 regulated by miR-532-3p promotes epithelial-to-mesenchymal transition and metastasis of hepatocellular carcinoma via gankyrin/AKT signaling |
| Q90429861 | The Oncoprotein Gankyrin/PSMD10 as a Target of Cancer Therapy |
Search more.